Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

STRIDES PHARMA SCIENCE LTD.

NSE : STARBSE : 532531ISIN CODE : INE939A01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE922.2510.85 (+1.19 %)
PREV CLOSE () 911.40
OPEN PRICE () 892.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 24611
TODAY'S LOW / HIGH ()888.20 935.80
52 WK LOW / HIGH ()551 1024.9
NSE921.6011.1 (+1.22 %)
PREV CLOSE() 910.50
OPEN PRICE () 911.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 921.60 (591)
VOLUME 360986
TODAY'S LOW / HIGH() 887.00 936.40
52 WK LOW / HIGH ()513.05 1025
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 1990

Management Info :

Arun Kumar - Chairman Badree Komandur - Managing Director

Registered Office :

Address : Cyberone, Unit No. 902,Plot No - 4 & 6,Sector 30 A, Vashi,
Navi Mumbai,
Maharashtra-400703

Phone : 022-27892924 / 3199

Website : www.strides.com

Registrar's Details : K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
18Feb Strides Pharma moves up as its arm acq
Strides Pharma Science is currently trading at Rs. 885.20, up by 4.65 po..
17Feb Strides Pharma’s arm acquires Neviton
Strides Pharma Science’s wholly owned subsidiary -- Arco Lab has complet..
05Feb Strides Pharma Science informs about
Strides Pharma Science has informed that it enclosed Press Release issue..
05Feb Strides Pharma’s arm gets USFDA inspec
Strides Pharma Science’s step-down wholly owned subsidiary in USA -- Str..
02Feb Response To Query Dated Feb 1, 2026 -
Response to BSE Query dated Feb 1, 2026 reference no. L/SURV/ONL/PV/APJ/..
Financials
in Millions
QTR Dec 25 ANNUAL 25
Net Profit1218.9528862.11
Gross Profit 1348.02 780.829999999999
Operating Profit 1844.423086.3
Net Sales 5536.3221394.23
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26916.10 (0.83%)
M.Cap ( in Cr)
57194.83
BDH Inds (BSE)
 402.35 (9.92%)
M.Cap ( in Cr)
231.64
Onesource Specialty (BSE)
 1488.70 (1.43%)
M.Cap ( in Cr)
17063.66
Mercury Laboratories (BSE)
 800.00 (2.56%)
M.Cap ( in Cr)
96.00
Jubilant Pharmova (BSE)
 840.90 (1.25%)
M.Cap ( in Cr)
13393.95
Shareholding Pattern
NON-INSTITUTION 29.59%
PROMOTERS 27.86%
MUTUAL FUNDS/UTI 8.59%
FI/BANKS/INSURANCE 3.06%
GOVERNMENT 0.01%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalparatu Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX74563.92-1470.50 (-1.93%)
NIFTY23151.10-488.05 (-2.06%)
Dow Jones 46558.47-119.38 (-0.26%)
Nasdaq 22105.36-206.62 (-0.93%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI